Decoding Healthcare Costs: Are You in One of These High-Spending Groups?
"A new study identifies key subgroups within Medicare Advantage, offering insights into where healthcare dollars are spent and how care can be improved."
The rising cost of healthcare is a major concern for everyone, especially as we age. We hear a lot about expensive treatments and wonder where all the money goes. A significant portion of healthcare spending is concentrated on a relatively small percentage of patients. Understanding who these individuals are and why they incur such high costs is crucial to improving the healthcare system for everyone.
Most research in this area has focused on those with traditional fee-for-service Medicare. However, an increasing number of people are enrolled in Medicare Advantage plans, which operate differently. That’s why a recent study published in the Journal of General Internal Medicine is so important. It dives deep into the characteristics of high-cost patients within a Medicare Advantage population, identifying distinct subgroups that drive the most spending.
This research provides valuable insights into how we can better manage care and allocate resources to improve outcomes and reduce costs. If you’re a patient, caregiver, or simply someone interested in understanding the complexities of healthcare spending, this breakdown is for you.
How Medicare Sets Payment Limits
CMS publishes Medicare Advantage advance notices, rate announcements, methodological changes, and special reports. Federal regulation at 42 CFR 413.30 establishes general rules for limits on reasonable costs recognized in Medicare payments for skilled nursing facilities and home health agencies. Separately, 42 CFR Part 422 sets standards, requirements, limitations, and procedures for services furnished or paid for through Medicare Advantage plans. A Health Affairs analysis reports that Medicare Advantage payment is based on what was coded, rather than what the clinical record actually documents.
From Basic Coverage to Medicare Advantage
CMS describes Medicare and Medicaid as having started as basic insurance programs for Americans without health insurance. Over time, they helped shape the modern foundation of American health care and became vital lifelines for older adults, people with disabilities, and low-income families. Medicare Advantage, also known as Part C, was added in 1996, formally allowing beneficiaries to receive Medicare benefits through private plans contracting with the federal government. The program has since undergone substantial evolution, including changes in popularity and regulation.
What Drives High Healthcare Costs? Unveiling Key Patient Subgroups
The study, conducted by Brian W. Powers et al., analyzed data from over 61,000 Medicare Advantage beneficiaries. The researchers used a sophisticated clustering algorithm to group high-cost patients (the top 10% of spenders) based on a variety of factors, including demographics, clinical conditions, and claims data. This approach allowed them to identify ten distinct subgroups within this high-cost population.
- Acute Exacerbations of Chronic Disease (Mixed): Often dealing with hospitalizations, these patients frequently experience conditions like cerebrovascular issues, COPD, heart problems, and mental health disorders. Preventable spending rates are notably high in this group.
- End-Stage Renal Disease (ESRD): Facing advanced kidney disease and undergoing dialysis, these patients are among the highest spenders and have a significant mortality rate.
- Recurrent Gastrointestinal Bleed (GIB): Characterized by repeated gastrointestinal bleeding and related complications, these individuals often require frequent hospital and ED visits.
- Orthopedic Trauma (Trauma): Dealing with fractures and other injuries, these patients have the highest rates of inpatient utilization.
- Vascular Disease (Vascular): Managing peripheral vascular disease, this group generally has lower utilization and spending rates compared to others.
- Surgical Infections and Other Complications (Complications): Experiencing surgical wound issues, infections, and iatrogenic complications, these patients often require inpatient care.
- Cirrhosis with Hepatitis C (Liver): Battling liver disease and hepatitis C, these patients have the highest average spending, largely driven by prescription drug costs.
- ESRD with Increased Medical and Behavioral Comorbidity (ESRD+): In addition to kidney disease, these patients face congestive heart failure, mental health disorders, and liver failure, leading to high rates of preventable spending and mortality.
- Cancer with High-Cost Imaging and Radiation Therapy (Oncology): Undergoing cancer treatment with extensive imaging and radiation, this group is predominantly male with prostate cancer being common.
- Neurologic Disorders (Neurologic): Managing various neurological conditions, including multiple sclerosis, these patients have high rates of persistent spending, primarily on prescription drugs.
What Recent Medicare Advantage Research Examines
A 2026 literature review synthesizes rigorous research on whether Medicare Advantage reduces health spending, increases federal expenditures, and produces better outcomes than Traditional Medicare. The reviewed studies use advanced empirical methods to address issues such as differences between the populations enrolled in the two programs. A 2025 Brown University research summary describes a proposed agenda that moves away from total-cost-of-care models toward reformed fee-for-service Medicare. Its proposals include more rigorous pricing of new technologies through value-based coverage, capped out-of-pocket costs, dental and vision benefits, and physician payment adjustments to support primary care.
Comparing Medicare Coverage Options
Recent comparison resources frame Original Medicare and Medicare Advantage as options that can be evaluated side by side. The dimensions identified across these resources include costs, doctor access, provider networks, prescription-drug coverage, extra benefits, and plan quality ratings. One 2027 comparison resource specifically presents plans, carriers, costs, benefits, and star ratings in a side-by-side chart. A 2026 cost-comparison tool emphasizes comparing actual annual costs rather than relying only on headline premiums.
A Path Forward: Tailoring Care to Reduce Spending and Improve Outcomes
The study's findings emphasize that a one-size-fits-all approach to managing high-cost patients simply won't work. To effectively address the challenge of rising healthcare costs, we need to move towards more personalized and targeted interventions. This means developing care management programs that are specifically designed to meet the unique needs of each subgroup. For example, patients with neurologic disorders may benefit most from strategies focused on medication management and adherence, while those with acute conditions may require interventions aimed at preventing hospital readmissions.
The Next Phase of Medicare Advantage
Recent outlooks describe Medicare as facing both significant challenges and opportunities as the health care landscape evolves. Forecasts for the next five years focus on costs, coverage, quality improvements, and changes in Medicare Advantage. Health plan leaders identify rising medical costs and utilization, pressure on Stars ratings, risk-adjustment model changes, and regulatory uncertainty as major forces shaping the market. These conditions are prompting health plans to reassess strategic priorities for 2026 and beyond.
Incentives, Access, and Network Pressure
A peer-reviewed overview describes Medicare Advantage as part of a transformation away from volume-based care toward incentives focused on improving health status. That approach can change how plans, clinicians, and health systems organize care and measure performance. At the same time, the Medicare Advocacy organization reports that hospitals and health systems nationwide have dropped or plan to drop Medicare Advantage contracts. This creates ongoing network challenges for beneficiaries who depend on stable access to participating providers.